Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraocular tissue plasminogen activator (t-PA) injection for macular diseases
jRCTs041180172Completed
- Start
- Feb 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of tissue-plasminogen activator in diabetic retinopathy (DR), Vein occlusion (RVO), age-related macular degeneration (AMD) and 2 more. Primary endpoint: visual acuity. Started Feb 2013; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
diabetic retinopathy (DR)Vein occlusion (RVO)age-related macular degeneration (AMD)Subretinal Hemorrhagemacular edema
Beyond the preview
Go deeper on jRCTs041180172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180172.